Close

Analyst Ratings for Gain Therapeutics (GANX) [Neutrals]

All Latest Ratings for GANX

GANX Rating Summary

GANX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GANX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.33 (+170.6%) * Over Last 12-Mos
Rating Score: 8.3 / 10   Percentile Rank: 86%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/19/2022 B.Riley Mayank Mamtani Downgrade Neutral
(Buy)		 5.00
(11.00)		 3.95
(3.08)		 -22.03% Details